EP4489751A4 - Medikament - Google Patents

Medikament

Info

Publication number
EP4489751A4
EP4489751A4 EP23767227.4A EP23767227A EP4489751A4 EP 4489751 A4 EP4489751 A4 EP 4489751A4 EP 23767227 A EP23767227 A EP 23767227A EP 4489751 A4 EP4489751 A4 EP 4489751A4
Authority
EP
European Patent Office
Prior art keywords
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP23767227.4A
Other languages
English (en)
French (fr)
Other versions
EP4489751A1 (de
Inventor
Hartley Atkinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AFT Pharmaceuticals Ltd
Original Assignee
AFT Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AFT Pharmaceuticals Ltd filed Critical AFT Pharmaceuticals Ltd
Publication of EP4489751A1 publication Critical patent/EP4489751A1/de
Publication of EP4489751A4 publication Critical patent/EP4489751A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
EP23767227.4A 2022-03-08 2023-02-23 Medikament Pending EP4489751A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2022201576A AU2022201576A1 (en) 2022-03-08 2022-03-08 Medication
PCT/NZ2023/050026 WO2023172148A1 (en) 2022-03-08 2023-02-23 Medication

Publications (2)

Publication Number Publication Date
EP4489751A1 EP4489751A1 (de) 2025-01-15
EP4489751A4 true EP4489751A4 (de) 2026-03-18

Family

ID=87935553

Family Applications (1)

Application Number Title Priority Date Filing Date
EP23767227.4A Pending EP4489751A4 (de) 2022-03-08 2023-02-23 Medikament

Country Status (3)

Country Link
EP (1) EP4489751A4 (de)
AU (3) AU2022201576A1 (de)
WO (1) WO2023172148A1 (de)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06506684A (ja) * 1991-04-01 1994-07-28 メルク　エンド　カンパニー　インコーポレーテッド イブプロフェン−充血除去剤配合物
US6087295A (en) * 1992-12-14 2000-07-11 Asec Manufacturing Reduction of NOx in the exhaust gases from internal combustion engines containing excess oxygen
WO2006016126A1 (en) * 2004-08-12 2006-02-16 Reckitt Benckiser Healthcare (Uk) Limited Granules comprising paracetamol a nsaid and a sugar alcohol made by melt extrusion
US20070077297A1 (en) * 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US10022339B2 (en) * 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20100288665A1 (en) * 2007-07-23 2010-11-18 Kingsway Pharmaceuticals Inc. Therapeutic formulations for the treatment of cold and flu-like symptoms
CN111617032A (zh) * 2020-07-08 2020-09-04 江苏四环生物制药有限公司 一种布洛芬药物纤维混悬剂及其制备方法

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "COLD AND FLU - ADULT - publication date PDF", 25 February 2014 (2014-02-25), XP093361893, Retrieved from the Internet <URL:https://cpsc.org.uk/> *
ANONYMOUS: "COLD AND FLU - ADULT - Publication google date on Community Pharmacy South Central", 1 May 2020 (2020-05-01), XP093361896, Retrieved from the Internet <URL:https://www.google.com/search?q=ibuprofen+xylometazoline+combination&sca_esv=30be4ccf2ba70406&rlz=1C1GCEW_enNL1133NL1133&source=lnt&tbs=cdr%3A1%2Ccd_min%3A%2Ccd_max%3A2022&tbm=> *
ANONYMOUS: "COLD AND FLU - ADULT - Recommendations Community Pharmacy Hampshire and Isle of Wight", 25 February 2014 (2014-02-25), XP093361890, Retrieved from the Internet <URL:https://cpsc.org.uk/application/files/3314/9200/1939/Cold_and_Flu_information_sheet.pdf> *
ANONYMOUS: "Maxigesic PE", 31 October 2020 (2020-10-31), XP093362107, Retrieved from the Internet <URL:https://www.medsafe.govt.nz/Consumers/CMI/m/MaxigesicPEtab.pdf> *
ECCLES RONALD ET AL: "The Nasal Decongestant Effect of Xylometazoline in the Common Cold", AMERICAN JOURNAL OF RHINOLOGY., vol. 22, no. 5, 1 September 2008 (2008-09-01), US, pages 491 - 496, XP093361482, ISSN: 1050-6586, Retrieved from the Internet <URL:https://journals.sagepub.com/doi/full-xml/10.2500/ajr.2008.22.3202> DOI: 10.2500/ajr.2008.22.3202 *
See also references of WO2023172148A1 *

Also Published As

Publication number Publication date
EP4489751A1 (de) 2025-01-15
WO2023172148A1 (en) 2023-09-14
AU2023230563A1 (en) 2024-09-05
AU2023222825A1 (en) 2023-09-28
AU2022201576A1 (en) 2023-09-28

Similar Documents

Publication Publication Date Title
EP4472980A4 (de) Chinazolin-pan-kras-hemmer
EP4479045A4 (de) Nlrp3-hemmer
EP4499646A4 (de) Nlrp3-inflammasom-inhibitoren
EP4483817A4 (de) Okkluder
EP4504722A4 (de) Lrrk2-hemmer
EP4504767A4 (de) Chimäre cytokinrezeptoren
EP4499630A4 (de) Bcl-xl-hemmer
EP4520976A4 (de) Turboverdichter
EP4434969A4 (de) Anti-sars-cov-2-arzneimittel
DE112023002022A5 (de) Isomatte
EP4497397A4 (de) Okkluder
EP4501308A4 (de) Haarwaschmittel
EP4241545C0 (de) Universal-biredder
CA3260666A1 (en) Combination therapies
EP4489751A4 (de) Medikament
CN309834577S (zh) 电子烟
CL2022002438S1 (es) Jeringa
CL2022002439S1 (es) Jeringa
CL2022002442S1 (es) Jeringa
CL2022002441S1 (es) Jeringa
JP1771399S (ja) 錠剤
JP1771401S (ja) 錠剤
JP1771311S (ja) 錠剤
JP1771400S (ja) 錠剤
JP1770233S (ja) 錠剤

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20240826

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20260216

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/4174 20060101AFI20260210BHEP

Ipc: A61K 31/167 20060101ALI20260210BHEP

Ipc: A61K 31/192 20060101ALI20260210BHEP

Ipc: A61P 29/00 20060101ALI20260210BHEP

Ipc: A61P 43/00 20060101ALI20260210BHEP